Net Loss Per Common Share (Details) - Schedule of potentially anti-dilutive shares - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Schedule Of Potentially Anti Dilutive Shares Abstract
Stock options issued and outstanding	1,862,358	1,385,855
Restricted stock units issued and outstanding	493,938	383,119
Conversion of Series 1 Convertible Preferred Stock	8,029,039	8,029,039
Total potentially dilutive shares	10,385,335	9,798,013